Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_assertion evidence source_evidence_literature NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_assertion SIO_000772 17118488 NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_assertion wasDerivedFrom befree-20140225 NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_assertion wasGeneratedBy ECO_0000203 NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- befree-20140225 importedOn "2014-02-25" NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.